 | • レポートコード：MRC2-11QY14425 • 出版社/出版日：QYResearch / 2020年11月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、154ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はプロプロテインコンバターゼサブチリシン/ケキシン9型のグローバル市場について調査・分析したレポートです。種類別（SX-PCK9、O-304、K-312、BLSM-201、DCRPCSK-9、その他）市場規模、用途別（心血管疾患、同種家族性高コレステロール血症、肝疾患、メタボリックシンドローム、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別プロプロテインコンバターゼサブチリシン/ケキシン9型の競争状況、市場シェア ・世界のプロプロテインコンバターゼサブチリシン/ケキシン9型市場：種類別市場規模 2015年-2020年（SX-PCK9、O-304、K-312、BLSM-201、DCRPCSK-9、その他） ・世界のプロプロテインコンバターゼサブチリシン/ケキシン9型市場：種類別市場規模予測 2021年-2026年（SX-PCK9、O-304、K-312、BLSM-201、DCRPCSK-9、その他） ・世界のプロプロテインコンバターゼサブチリシン/ケキシン9型市場：用途別市場規模 2015年-2020年（心血管疾患、同種家族性高コレステロール血症、肝疾患、メタボリックシンドローム、その他） ・世界のプロプロテインコンバターゼサブチリシン/ケキシン9型市場：用途別市場規模予測 2021年-2026年（心血管疾患、同種家族性高コレステロール血症、肝疾患、メタボリックシンドローム、その他） ・北米のプロプロテインコンバターゼサブチリシン/ケキシン9型市場分析：米国、カナダ ・ヨーロッパのプロプロテインコンバターゼサブチリシン/ケキシン9型市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのプロプロテインコンバターゼサブチリシン/ケキシン9型市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のプロプロテインコンバターゼサブチリシン/ケキシン9型市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのプロプロテインコンバターゼサブチリシン/ケキシン9型市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：AFFiRiS AG、Betagenon AB、Bioleaders Corp、BioLingus AG、Catabasis Pharmaceuticals Inc、Dicerna Pharmaceuticals Inc、Eli Lilly and Co、Ensemble Therapeutics Corp、Kowa Co Ltd、Novartis AG、Pfizer Inc、Regeneron Pharmaceuticals Inc、Serometrix LLC、Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd、The Medicines Company ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Proprotein Convertase Subtilisin/Kexin Type 9 Market
The global Proprotein Convertase Subtilisin/Kexin Type 9 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Proprotein Convertase Subtilisin/Kexin Type 9 Scope and Market Size
Proprotein Convertase Subtilisin/Kexin Type 9 market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Proprotein Convertase Subtilisin/Kexin Type 9 market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Proprotein Convertase Subtilisin/Kexin Type 9 market is segmented into
SX-PCK9
O-304
K-312
BLSM-201
DCRPCSK-9
Others
Segment by Application, the Proprotein Convertase Subtilisin/Kexin Type 9 market is segmented into
Cardiovascular Disease
Homozugous Familial Hyperchalesterolemia
Liver Disease
Metabolic Syndrome
Others
Regional and Country-level Analysis
The Proprotein Convertase Subtilisin/Kexin Type 9 market is analysed and market size information is provided by regions (countries).
The key regions covered in the Proprotein Convertase Subtilisin/Kexin Type 9 market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Proprotein Convertase Subtilisin/Kexin Type 9 Market Share Analysis
Proprotein Convertase Subtilisin/Kexin Type 9 market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Proprotein Convertase Subtilisin/Kexin Type 9 business, the date to enter into the Proprotein Convertase Subtilisin/Kexin Type 9 market, Proprotein Convertase Subtilisin/Kexin Type 9 product introduction, recent developments, etc.
The major vendors covered:
AFFiRiS AG
Betagenon AB
Bioleaders Corp
BioLingus AG
Catabasis Pharmaceuticals Inc
Dicerna Pharmaceuticals Inc
Eli Lilly and Co
Ensemble Therapeutics Corp
Kowa Co Ltd
Novartis AG
Pfizer Inc
Regeneron Pharmaceuticals Inc
Serometrix LLC
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd
The Medicines Company
1 Study Coverage
1.1 Proprotein Convertase Subtilisin/Kexin Type 9 Product Introduction
1.2 Market Segments
1.3 Key Proprotein Convertase Subtilisin/Kexin Type 9 Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Growth Rate by Type
1.4.2 SX-PCK9
1.4.3 O-304
1.4.4 K-312
1.4.5 BLSM-201
1.4.6 DCRPCSK-9
1.4.7 Others
1.5 Market by Application
1.5.1 Global Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Growth Rate by Application
1.5.2 Cardiovascular Disease
1.5.3 Homozugous Familial Hyperchalesterolemia
1.5.4 Liver Disease
1.5.5 Metabolic Syndrome
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Proprotein Convertase Subtilisin/Kexin Type 9 Market Size, Estimates and Forecasts
2.1.1 Global Proprotein Convertase Subtilisin/Kexin Type 9 Revenue 2015-2026
2.1.2 Global Proprotein Convertase Subtilisin/Kexin Type 9 Sales 2015-2026
2.2 Global Proprotein Convertase Subtilisin/Kexin Type 9, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Proprotein Convertase Subtilisin/Kexin Type 9 Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Proprotein Convertase Subtilisin/Kexin Type 9 Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Proprotein Convertase Subtilisin/Kexin Type 9 Competitor Landscape by Players
3.1 Proprotein Convertase Subtilisin/Kexin Type 9 Sales by Manufacturers
3.1.1 Proprotein Convertase Subtilisin/Kexin Type 9 Sales by Manufacturers (2015-2020)
3.1.2 Proprotein Convertase Subtilisin/Kexin Type 9 Sales Market Share by Manufacturers (2015-2020)
3.2 Proprotein Convertase Subtilisin/Kexin Type 9 Revenue by Manufacturers
3.2.1 Proprotein Convertase Subtilisin/Kexin Type 9 Revenue by Manufacturers (2015-2020)
3.2.2 Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Proprotein Convertase Subtilisin/Kexin Type 9 Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Proprotein Convertase Subtilisin/Kexin Type 9 Revenue in 2019
3.2.5 Global Proprotein Convertase Subtilisin/Kexin Type 9 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Proprotein Convertase Subtilisin/Kexin Type 9 Price by Manufacturers
3.4 Proprotein Convertase Subtilisin/Kexin Type 9 Manufacturing Base Distribution, Product Types
3.4.1 Proprotein Convertase Subtilisin/Kexin Type 9 Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Proprotein Convertase Subtilisin/Kexin Type 9 Product Type
3.4.3 Date of International Manufacturers Enter into Proprotein Convertase Subtilisin/Kexin Type 9 Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Proprotein Convertase Subtilisin/Kexin Type 9 Market Size by Type (2015-2020)
4.1.1 Global Proprotein Convertase Subtilisin/Kexin Type 9 Sales by Type (2015-2020)
4.1.2 Global Proprotein Convertase Subtilisin/Kexin Type 9 Revenue by Type (2015-2020)
4.1.3 Proprotein Convertase Subtilisin/Kexin Type 9 Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Forecast by Type (2021-2026)
4.2.1 Global Proprotein Convertase Subtilisin/Kexin Type 9 Sales Forecast by Type (2021-2026)
4.2.2 Global Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Forecast by Type (2021-2026)
4.2.3 Proprotein Convertase Subtilisin/Kexin Type 9 Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Proprotein Convertase Subtilisin/Kexin Type 9 Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Proprotein Convertase Subtilisin/Kexin Type 9 Market Size by Application (2015-2020)
5.1.1 Global Proprotein Convertase Subtilisin/Kexin Type 9 Sales by Application (2015-2020)
5.1.2 Global Proprotein Convertase Subtilisin/Kexin Type 9 Revenue by Application (2015-2020)
5.1.3 Proprotein Convertase Subtilisin/Kexin Type 9 Price by Application (2015-2020)
5.2 Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Forecast by Application (2021-2026)
5.2.1 Global Proprotein Convertase Subtilisin/Kexin Type 9 Sales Forecast by Application (2021-2026)
5.2.2 Global Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Forecast by Application (2021-2026)
5.2.3 Global Proprotein Convertase Subtilisin/Kexin Type 9 Price Forecast by Application (2021-2026)
6 North America
6.1 North America Proprotein Convertase Subtilisin/Kexin Type 9 by Country
6.1.1 North America Proprotein Convertase Subtilisin/Kexin Type 9 Sales by Country
6.1.2 North America Proprotein Convertase Subtilisin/Kexin Type 9 Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Proprotein Convertase Subtilisin/Kexin Type 9 Market Facts & Figures by Type
6.3 North America Proprotein Convertase Subtilisin/Kexin Type 9 Market Facts & Figures by Application
7 Europe
7.1 Europe Proprotein Convertase Subtilisin/Kexin Type 9 by Country
7.1.1 Europe Proprotein Convertase Subtilisin/Kexin Type 9 Sales by Country
7.1.2 Europe Proprotein Convertase Subtilisin/Kexin Type 9 Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Proprotein Convertase Subtilisin/Kexin Type 9 Market Facts & Figures by Type
7.3 Europe Proprotein Convertase Subtilisin/Kexin Type 9 Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Proprotein Convertase Subtilisin/Kexin Type 9 by Region
8.1.1 Asia Pacific Proprotein Convertase Subtilisin/Kexin Type 9 Sales by Region
8.1.2 Asia Pacific Proprotein Convertase Subtilisin/Kexin Type 9 Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Proprotein Convertase Subtilisin/Kexin Type 9 Market Facts & Figures by Type
8.3 Asia Pacific Proprotein Convertase Subtilisin/Kexin Type 9 Market Facts & Figures by Application
9 Latin America
9.1 Latin America Proprotein Convertase Subtilisin/Kexin Type 9 by Country
9.1.1 Latin America Proprotein Convertase Subtilisin/Kexin Type 9 Sales by Country
9.1.2 Latin America Proprotein Convertase Subtilisin/Kexin Type 9 Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Proprotein Convertase Subtilisin/Kexin Type 9 Market Facts & Figures by Type
9.3 Central & South America Proprotein Convertase Subtilisin/Kexin Type 9 Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Proprotein Convertase Subtilisin/Kexin Type 9 by Country
10.1.1 Middle East and Africa Proprotein Convertase Subtilisin/Kexin Type 9 Sales by Country
10.1.2 Middle East and Africa Proprotein Convertase Subtilisin/Kexin Type 9 Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Proprotein Convertase Subtilisin/Kexin Type 9 Market Facts & Figures by Type
10.3 Middle East and Africa Proprotein Convertase Subtilisin/Kexin Type 9 Market Facts & Figures by Application
11 Company Profiles
11.1 AFFiRiS AG
11.1.1 AFFiRiS AG Corporation Information
11.1.2 AFFiRiS AG Description and Business Overview
11.1.3 AFFiRiS AG Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AFFiRiS AG Proprotein Convertase Subtilisin/Kexin Type 9 Products Offered
11.1.5 AFFiRiS AG Related Developments
11.2 Betagenon AB
11.2.1 Betagenon AB Corporation Information
11.2.2 Betagenon AB Description and Business Overview
11.2.3 Betagenon AB Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Betagenon AB Proprotein Convertase Subtilisin/Kexin Type 9 Products Offered
11.2.5 Betagenon AB Related Developments
11.3 Bioleaders Corp
11.3.1 Bioleaders Corp Corporation Information
11.3.2 Bioleaders Corp Description and Business Overview
11.3.3 Bioleaders Corp Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Bioleaders Corp Proprotein Convertase Subtilisin/Kexin Type 9 Products Offered
11.3.5 Bioleaders Corp Related Developments
11.4 BioLingus AG
11.4.1 BioLingus AG Corporation Information
11.4.2 BioLingus AG Description and Business Overview
11.4.3 BioLingus AG Sales, Revenue and Gross Margin (2015-2020)
11.4.4 BioLingus AG Proprotein Convertase Subtilisin/Kexin Type 9 Products Offered
11.4.5 BioLingus AG Related Developments
11.5 Catabasis Pharmaceuticals Inc
11.5.1 Catabasis Pharmaceuticals Inc Corporation Information
11.5.2 Catabasis Pharmaceuticals Inc Description and Business Overview
11.5.3 Catabasis Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Catabasis Pharmaceuticals Inc Proprotein Convertase Subtilisin/Kexin Type 9 Products Offered
11.5.5 Catabasis Pharmaceuticals Inc Related Developments
11.6 Dicerna Pharmaceuticals Inc
11.6.1 Dicerna Pharmaceuticals Inc Corporation Information
11.6.2 Dicerna Pharmaceuticals Inc Description and Business Overview
11.6.3 Dicerna Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Dicerna Pharmaceuticals Inc Proprotein Convertase Subtilisin/Kexin Type 9 Products Offered
11.6.5 Dicerna Pharmaceuticals Inc Related Developments
11.7 Eli Lilly and Co
11.7.1 Eli Lilly and Co Corporation Information
11.7.2 Eli Lilly and Co Description and Business Overview
11.7.3 Eli Lilly and Co Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Eli Lilly and Co Proprotein Convertase Subtilisin/Kexin Type 9 Products Offered
11.7.5 Eli Lilly and Co Related Developments
11.8 Ensemble Therapeutics Corp
11.8.1 Ensemble Therapeutics Corp Corporation Information
11.8.2 Ensemble Therapeutics Corp Description and Business Overview
11.8.3 Ensemble Therapeutics Corp Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Ensemble Therapeutics Corp Proprotein Convertase Subtilisin/Kexin Type 9 Products Offered
11.8.5 Ensemble Therapeutics Corp Related Developments
11.9 Kowa Co Ltd
11.9.1 Kowa Co Ltd Corporation Information
11.9.2 Kowa Co Ltd Description and Business Overview
11.9.3 Kowa Co Ltd Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Kowa Co Ltd Proprotein Convertase Subtilisin/Kexin Type 9 Products Offered
11.9.5 Kowa Co Ltd Related Developments
11.10 Novartis AG
11.10.1 Novartis AG Corporation Information
11.10.2 Novartis AG Description and Business Overview
11.10.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Novartis AG Proprotein Convertase Subtilisin/Kexin Type 9 Products Offered
11.10.5 Novartis AG Related Developments
11.1 AFFiRiS AG
11.1.1 AFFiRiS AG Corporation Information
11.1.2 AFFiRiS AG Description and Business Overview
11.1.3 AFFiRiS AG Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AFFiRiS AG Proprotein Convertase Subtilisin/Kexin Type 9 Products Offered
11.1.5 AFFiRiS AG Related Developments
11.12 Regeneron Pharmaceuticals Inc
11.12.1 Regeneron Pharmaceuticals Inc Corporation Information
11.12.2 Regeneron Pharmaceuticals Inc Description and Business Overview
11.12.3 Regeneron Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Regeneron Pharmaceuticals Inc Products Offered
11.12.5 Regeneron Pharmaceuticals Inc Related Developments
11.13 Serometrix LLC
11.13.1 Serometrix LLC Corporation Information
11.13.2 Serometrix LLC Description and Business Overview
11.13.3 Serometrix LLC Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Serometrix LLC Products Offered
11.13.5 Serometrix LLC Related Developments
11.14 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd
11.14.1 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Corporation Information
11.14.2 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Description and Business Overview
11.14.3 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Products Offered
11.14.5 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Related Developments
11.15 The Medicines Company
11.15.1 The Medicines Company Corporation Information
11.15.2 The Medicines Company Description and Business Overview
11.15.3 The Medicines Company Sales, Revenue and Gross Margin (2015-2020)
11.15.4 The Medicines Company Products Offered
11.15.5 The Medicines Company Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Proprotein Convertase Subtilisin/Kexin Type 9 Market Estimates and Projections by Region
12.1.1 Global Proprotein Convertase Subtilisin/Kexin Type 9 Sales Forecast by Regions 2021-2026
12.1.2 Global Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Forecast by Regions 2021-2026
12.2 North America Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Forecast (2021-2026)
12.2.1 North America: Proprotein Convertase Subtilisin/Kexin Type 9 Sales Forecast (2021-2026)
12.2.2 North America: Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Forecast (2021-2026)
12.2.3 North America: Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Forecast by Country (2021-2026)
12.3 Europe Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Forecast (2021-2026)
12.3.1 Europe: Proprotein Convertase Subtilisin/Kexin Type 9 Sales Forecast (2021-2026)
12.3.2 Europe: Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Forecast (2021-2026)
12.3.3 Europe: Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Proprotein Convertase Subtilisin/Kexin Type 9 Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Forecast by Region (2021-2026)
12.5 Latin America Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Forecast (2021-2026)
12.5.1 Latin America: Proprotein Convertase Subtilisin/Kexin Type 9 Sales Forecast (2021-2026)
12.5.2 Latin America: Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Forecast (2021-2026)
12.5.3 Latin America: Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Proprotein Convertase Subtilisin/Kexin Type 9 Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Proprotein Convertase Subtilisin/Kexin Type 9 Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Proprotein Convertase Subtilisin/Kexin Type 9 Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Proprotein Convertase Subtilisin/Kexin Type 9 Market Segments
Table 2. Ranking of Global Top Proprotein Convertase Subtilisin/Kexin Type 9 Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of SX-PCK9
Table 5. Major Manufacturers of O-304
Table 6. Major Manufacturers of K-312
Table 7. Major Manufacturers of BLSM-201
Table 8. Major Manufacturers of DCRPCSK-9
Table 9. Major Manufacturers of Others
Table 10. Global Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 11. Global Proprotein Convertase Subtilisin/Kexin Type 9 Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 12. Global Proprotein Convertase Subtilisin/Kexin Type 9 Sales by Regions 2015-2020 (K Pcs)
Table 13. Global Proprotein Convertase Subtilisin/Kexin Type 9 Sales Market Share by Regions (2015-2020)
Table 14. Global Proprotein Convertase Subtilisin/Kexin Type 9 Revenue by Regions 2015-2020 (US$ Million)
Table 15. Global Proprotein Convertase Subtilisin/Kexin Type 9 Sales by Manufacturers (2015-2020) (K Pcs)
Table 16. Global Proprotein Convertase Subtilisin/Kexin Type 9 Sales Share by Manufacturers (2015-2020)
Table 17. Global Proprotein Convertase Subtilisin/Kexin Type 9 Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 18. Global Proprotein Convertase Subtilisin/Kexin Type 9 by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Proprotein Convertase Subtilisin/Kexin Type 9 as of 2019)
Table 19. Proprotein Convertase Subtilisin/Kexin Type 9 Revenue by Manufacturers (2015-2020) (US$ Million)
Table 20. Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Share by Manufacturers (2015-2020)
Table 21. Key Manufacturers Proprotein Convertase Subtilisin/Kexin Type 9 Price (2015-2020) (USD/Pcs)
Table 22. Proprotein Convertase Subtilisin/Kexin Type 9 Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Proprotein Convertase Subtilisin/Kexin Type 9 Product Type
Table 24. Date of International Manufacturers Enter into Proprotein Convertase Subtilisin/Kexin Type 9 Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Proprotein Convertase Subtilisin/Kexin Type 9 Sales by Type (2015-2020) (K Pcs)
Table 27. Global Proprotein Convertase Subtilisin/Kexin Type 9 Sales Share by Type (2015-2020)
Table 28. Global Proprotein Convertase Subtilisin/Kexin Type 9 Revenue by Type (2015-2020) (US$ Million)
Table 29. Global Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Share by Type (2015-2020)
Table 30. Proprotein Convertase Subtilisin/Kexin Type 9 Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 31. Global Proprotein Convertase Subtilisin/Kexin Type 9 Sales by Application (2015-2020) (K Pcs)
Table 32. Global Proprotein Convertase Subtilisin/Kexin Type 9 Sales Share by Application (2015-2020)
Table 33. North America Proprotein Convertase Subtilisin/Kexin Type 9 Sales by Country (2015-2020) (K Pcs)
Table 34. North America Proprotein Convertase Subtilisin/Kexin Type 9 Sales Market Share by Country (2015-2020)
Table 35. North America Proprotein Convertase Subtilisin/Kexin Type 9 Revenue by Country (2015-2020) (US$ Million)
Table 36. North America Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Market Share by Country (2015-2020)
Table 37. North America Proprotein Convertase Subtilisin/Kexin Type 9 Sales by Type (2015-2020) (K Pcs)
Table 38. North America Proprotein Convertase Subtilisin/Kexin Type 9 Sales Market Share by Type (2015-2020)
Table 39. North America Proprotein Convertase Subtilisin/Kexin Type 9 Sales by Application (2015-2020) (K Pcs)
Table 40. North America Proprotein Convertase Subtilisin/Kexin Type 9 Sales Market Share by Application (2015-2020)
Table 41. Europe Proprotein Convertase Subtilisin/Kexin Type 9 Sales by Country (2015-2020) (K Pcs)
Table 42. Europe Proprotein Convertase Subtilisin/Kexin Type 9 Sales Market Share by Country (2015-2020)
Table 43. Europe Proprotein Convertase Subtilisin/Kexin Type 9 Revenue by Country (2015-2020) (US$ Million)
Table 44. Europe Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Market Share by Country (2015-2020)
Table 45. Europe Proprotein Convertase Subtilisin/Kexin Type 9 Sales by Type (2015-2020) (K Pcs)
Table 46. Europe Proprotein Convertase Subtilisin/Kexin Type 9 Sales Market Share by Type (2015-2020)
Table 47. Europe Proprotein Convertase Subtilisin/Kexin Type 9 Sales by Application (2015-2020) (K Pcs)
Table 48. Europe Proprotein Convertase Subtilisin/Kexin Type 9 Sales Market Share by Application (2015-2020)
Table 49. Asia Pacific Proprotein Convertase Subtilisin/Kexin Type 9 Sales by Region (2015-2020) (K Pcs)
Table 50. Asia Pacific Proprotein Convertase Subtilisin/Kexin Type 9 Sales Market Share by Region (2015-2020)
Table 51. Asia Pacific Proprotein Convertase Subtilisin/Kexin Type 9 Revenue by Region (2015-2020) (US$ Million)
Table 52. Asia Pacific Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Market Share by Region (2015-2020)
Table 53. Asia Pacific Proprotein Convertase Subtilisin/Kexin Type 9 Sales by Type (2015-2020) (K Pcs)
Table 54. Asia Pacific Proprotein Convertase Subtilisin/Kexin Type 9 Sales Market Share by Type (2015-2020)
Table 55. Asia Pacific Proprotein Convertase Subtilisin/Kexin Type 9 Sales by Application (2015-2020) (K Pcs)
Table 56. Asia Pacific Proprotein Convertase Subtilisin/Kexin Type 9 Sales Market Share by Application (2015-2020)
Table 57. Latin America Proprotein Convertase Subtilisin/Kexin Type 9 Sales by Country (2015-2020) (K Pcs)
Table 58. Latin America Proprotein Convertase Subtilisin/Kexin Type 9 Sales Market Share by Country (2015-2020)
Table 59. Latin Americaa Proprotein Convertase Subtilisin/Kexin Type 9 Revenue by Country (2015-2020) (US$ Million)
Table 60. Latin America Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Market Share by Country (2015-2020)
Table 61. Latin America Proprotein Convertase Subtilisin/Kexin Type 9 Sales by Type (2015-2020) (K Pcs)
Table 62. Latin America Proprotein Convertase Subtilisin/Kexin Type 9 Sales Market Share by Type (2015-2020)
Table 63. Latin America Proprotein Convertase Subtilisin/Kexin Type 9 Sales by Application (2015-2020) (K Pcs)
Table 64. Latin America Proprotein Convertase Subtilisin/Kexin Type 9 Sales Market Share by Application (2015-2020)
Table 65. Middle East and Africa Proprotein Convertase Subtilisin/Kexin Type 9 Sales by Country (2015-2020) (K Pcs)
Table 66. Middle East and Africa Proprotein Convertase Subtilisin/Kexin Type 9 Sales Market Share by Country (2015-2020)
Table 67. Middle East and Africa Proprotein Convertase Subtilisin/Kexin Type 9 Revenue by Country (2015-2020) (US$ Million)
Table 68. Middle East and Africa Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Market Share by Country (2015-2020)
Table 69. Middle East and Africa Proprotein Convertase Subtilisin/Kexin Type 9 Sales by Type (2015-2020) (K Pcs)
Table 70. Middle East and Africa Proprotein Convertase Subtilisin/Kexin Type 9 Sales Market Share by Type (2015-2020)
Table 71. Middle East and Africa Proprotein Convertase Subtilisin/Kexin Type 9 Sales by Application (2015-2020) (K Pcs)
Table 72. Middle East and Africa Proprotein Convertase Subtilisin/Kexin Type 9 Sales Market Share by Application (2015-2020)
Table 73. AFFiRiS AG Corporation Information
Table 74. AFFiRiS AG Description and Major Businesses
Table 75. AFFiRiS AG Proprotein Convertase Subtilisin/Kexin Type 9 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 76. AFFiRiS AG Product
Table 77. AFFiRiS AG Recent Development
Table 78. Betagenon AB Corporation Information
Table 79. Betagenon AB Description and Major Businesses
Table 80. Betagenon AB Proprotein Convertase Subtilisin/Kexin Type 9 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 81. Betagenon AB Product
Table 82. Betagenon AB Recent Development
Table 83. Bioleaders Corp Corporation Information
Table 84. Bioleaders Corp Description and Major Businesses
Table 85. Bioleaders Corp Proprotein Convertase Subtilisin/Kexin Type 9 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 86. Bioleaders Corp Product
Table 87. Bioleaders Corp Recent Development
Table 88. BioLingus AG Corporation Information
Table 89. BioLingus AG Description and Major Businesses
Table 90. BioLingus AG Proprotein Convertase Subtilisin/Kexin Type 9 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 91. BioLingus AG Product
Table 92. BioLingus AG Recent Development
Table 93. Catabasis Pharmaceuticals Inc Corporation Information
Table 94. Catabasis Pharmaceuticals Inc Description and Major Businesses
Table 95. Catabasis Pharmaceuticals Inc Proprotein Convertase Subtilisin/Kexin Type 9 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 96. Catabasis Pharmaceuticals Inc Product
Table 97. Catabasis Pharmaceuticals Inc Recent Development
Table 98. Dicerna Pharmaceuticals Inc Corporation Information
Table 99. Dicerna Pharmaceuticals Inc Description and Major Businesses
Table 100. Dicerna Pharmaceuticals Inc Proprotein Convertase Subtilisin/Kexin Type 9 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 101. Dicerna Pharmaceuticals Inc Product
Table 102. Dicerna Pharmaceuticals Inc Recent Development
Table 103. Eli Lilly and Co Corporation Information
Table 104. Eli Lilly and Co Description and Major Businesses
Table 105. Eli Lilly and Co Proprotein Convertase Subtilisin/Kexin Type 9 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 106. Eli Lilly and Co Product
Table 107. Eli Lilly and Co Recent Development
Table 108. Ensemble Therapeutics Corp Corporation Information
Table 109. Ensemble Therapeutics Corp Description and Major Businesses
Table 110. Ensemble Therapeutics Corp Proprotein Convertase Subtilisin/Kexin Type 9 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 111. Ensemble Therapeutics Corp Product
Table 112. Ensemble Therapeutics Corp Recent Development
Table 113. Kowa Co Ltd Corporation Information
Table 114. Kowa Co Ltd Description and Major Businesses
Table 115. Kowa Co Ltd Proprotein Convertase Subtilisin/Kexin Type 9 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 116. Kowa Co Ltd Product
Table 117. Kowa Co Ltd Recent Development
Table 118. Novartis AG Corporation Information
Table 119. Novartis AG Description and Major Businesses
Table 120. Novartis AG Proprotein Convertase Subtilisin/Kexin Type 9 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 121. Novartis AG Product
Table 122. Novartis AG Recent Development
Table 123. Pfizer Inc Corporation Information
Table 124. Pfizer Inc Description and Major Businesses
Table 125. Pfizer Inc Proprotein Convertase Subtilisin/Kexin Type 9 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 126. Pfizer Inc Product
Table 127. Pfizer Inc Recent Development
Table 128. Regeneron Pharmaceuticals Inc Corporation Information
Table 129. Regeneron Pharmaceuticals Inc Description and Major Businesses
Table 130. Regeneron Pharmaceuticals Inc Proprotein Convertase Subtilisin/Kexin Type 9 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 131. Regeneron Pharmaceuticals Inc Product
Table 132. Regeneron Pharmaceuticals Inc Recent Development
Table 133. Serometrix LLC Corporation Information
Table 134. Serometrix LLC Description and Major Businesses
Table 135. Serometrix LLC Proprotein Convertase Subtilisin/Kexin Type 9 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 136. Serometrix LLC Product
Table 137. Serometrix LLC Recent Development
Table 138. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Corporation Information
Table 139. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Description and Major Businesses
Table 140. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Proprotein Convertase Subtilisin/Kexin Type 9 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 141. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Product
Table 142. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Recent Development
Table 143. The Medicines Company Corporation Information
Table 144. The Medicines Company Description and Major Businesses
Table 145. The Medicines Company Proprotein Convertase Subtilisin/Kexin Type 9 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 146. The Medicines Company Product
Table 147. The Medicines Company Recent Development
Table 148. Global Proprotein Convertase Subtilisin/Kexin Type 9 Sales Forecast by Regions (2021-2026) (K Pcs)
Table 149. Global Proprotein Convertase Subtilisin/Kexin Type 9 Sales Market Share Forecast by Regions (2021-2026)
Table 150. Global Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 151. Global Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Market Share Forecast by Regions (2021-2026)
Table 152. North America: Proprotein Convertase Subtilisin/Kexin Type 9 Sales Forecast by Country (2021-2026) (K Pcs)
Table 153. North America: Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 154. Europe: Proprotein Convertase Subtilisin/Kexin Type 9 Sales Forecast by Country (2021-2026) (K Pcs)
Table 155. Europe: Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 156. Asia Pacific: Proprotein Convertase Subtilisin/Kexin Type 9 Sales Forecast by Region (2021-2026) (K Pcs)
Table 157. Asia Pacific: Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Forecast by Region (2021-2026) (US$ Million)
Table 158. Latin America: Proprotein Convertase Subtilisin/Kexin Type 9 Sales Forecast by Country (2021-2026) (K Pcs)
Table 159. Latin America: Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 160. Middle East and Africa: Proprotein Convertase Subtilisin/Kexin Type 9 Sales Forecast by Country (2021-2026) (K Pcs)
Table 161. Middle East and Africa: Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 162. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 163. Key Challenges
Table 164. Market Risks
Table 165. Main Points Interviewed from Key Proprotein Convertase Subtilisin/Kexin Type 9 Players
Table 166. Proprotein Convertase Subtilisin/Kexin Type 9 Customers List
Table 167. Proprotein Convertase Subtilisin/Kexin Type 9 Distributors List
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Proprotein Convertase Subtilisin/Kexin Type 9 Product Picture
Figure 2. Global Proprotein Convertase Subtilisin/Kexin Type 9 Sales Market Share by Type in 2020 & 2026
Figure 3. SX-PCK9 Product Picture
Figure 4. O-304 Product Picture
Figure 5. K-312 Product Picture
Figure 6. BLSM-201 Product Picture
Figure 7. DCRPCSK-9 Product Picture
Figure 8. Others Product Picture
Figure 9. Global Proprotein Convertase Subtilisin/Kexin Type 9 Sales Market Share by Application in 2020 & 2026
Figure 10. Cardiovascular Disease
Figure 11. Homozugous Familial Hyperchalesterolemia
Figure 12. Liver Disease
Figure 13. Metabolic Syndrome
Figure 14. Others
Figure 15. Proprotein Convertase Subtilisin/Kexin Type 9 Report Years Considered
Figure 16. Global Proprotein Convertase Subtilisin/Kexin Type 9 Market Size 2015-2026 (US$ Million)
Figure 17. Global Proprotein Convertase Subtilisin/Kexin Type 9 Sales 2015-2026 (K Pcs)
Figure 18. Global Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Market Share by Region: 2020 Versus 2026
Figure 19. Global Proprotein Convertase Subtilisin/Kexin Type 9 Sales Market Share by Region (2015-2020)
Figure 20. Global Proprotein Convertase Subtilisin/Kexin Type 9 Sales Market Share by Region in 2019
Figure 21. Global Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Market Share by Region (2015-2020)
Figure 22. Global Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Market Share by Region in 2019
Figure 23. Global Proprotein Convertase Subtilisin/Kexin Type 9 Sales Share by Manufacturer in 2019
Figure 24. The Top 10 and 5 Players Market Share by Proprotein Convertase Subtilisin/Kexin Type 9 Revenue in 2019
Figure 25. Proprotein Convertase Subtilisin/Kexin Type 9 Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 26. Global Proprotein Convertase Subtilisin/Kexin Type 9 Sales Market Share by Type (2015-2020)
Figure 27. Global Proprotein Convertase Subtilisin/Kexin Type 9 Sales Market Share by Type in 2019
Figure 28. Global Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Market Share by Type (2015-2020)
Figure 29. Global Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Market Share by Type in 2019
Figure 30. Global Proprotein Convertase Subtilisin/Kexin Type 9 Market Share by Price Range (2015-2020)
Figure 31. Global Proprotein Convertase Subtilisin/Kexin Type 9 Sales Market Share by Application (2015-2020)
Figure 32. Global Proprotein Convertase Subtilisin/Kexin Type 9 Sales Market Share by Application in 2019
Figure 33. Global Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Market Share by Application (2015-2020)
Figure 34. Global Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Market Share by Application in 2019
Figure 35. North America Proprotein Convertase Subtilisin/Kexin Type 9 Sales Growth Rate 2015-2020 (K Pcs)
Figure 36. North America Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 37. North America Proprotein Convertase Subtilisin/Kexin Type 9 Sales Market Share by Country in 2019
Figure 38. North America Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Market Share by Country in 2019
Figure 39. U.S. Proprotein Convertase Subtilisin/Kexin Type 9 Sales Growth Rate (2015-2020) (K Pcs)
Figure 40. U.S. Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. Canada Proprotein Convertase Subtilisin/Kexin Type 9 Sales Growth Rate (2015-2020) (K Pcs)
Figure 42. Canada Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. North America Proprotein Convertase Subtilisin/Kexin Type 9 Market Share by Type in 2019
Figure 44. North America Proprotein Convertase Subtilisin/Kexin Type 9 Market Share by Application in 2019
Figure 45. Europe Proprotein Convertase Subtilisin/Kexin Type 9 Sales Growth Rate 2015-2020 (K Pcs)
Figure 46. Europe Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 47. Europe Proprotein Convertase Subtilisin/Kexin Type 9 Sales Market Share by Country in 2019
Figure 48. Europe Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Market Share by Country in 2019
Figure 49. Germany Proprotein Convertase Subtilisin/Kexin Type 9 Sales Growth Rate (2015-2020) (K Pcs)
Figure 50. Germany Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. France Proprotein Convertase Subtilisin/Kexin Type 9 Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. France Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. U.K. Proprotein Convertase Subtilisin/Kexin Type 9 Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. U.K. Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Italy Proprotein Convertase Subtilisin/Kexin Type 9 Sales Growth Rate (2015-2020) (K Pcs)
Figure 56. Italy Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Russia Proprotein Convertase Subtilisin/Kexin Type 9 Sales Growth Rate (2015-2020) (K Pcs)
Figure 58. Russia Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Europe Proprotein Convertase Subtilisin/Kexin Type 9 Market Share by Type in 2019
Figure 60. Europe Proprotein Convertase Subtilisin/Kexin Type 9 Market Share by Application in 2019
Figure 61. Asia Pacific Proprotein Convertase Subtilisin/Kexin Type 9 Sales Growth Rate 2015-2020 (K Pcs)
Figure 62. Asia Pacific Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 63. Asia Pacific Proprotein Convertase Subtilisin/Kexin Type 9 Sales Market Share by Region in 2019
Figure 64. Asia Pacific Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Market Share by Region in 2019
Figure 65. China Proprotein Convertase Subtilisin/Kexin Type 9 Sales Growth Rate (2015-2020) (K Pcs)
Figure 66. China Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Japan Proprotein Convertase Subtilisin/Kexin Type 9 Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. Japan Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. South Korea Proprotein Convertase Subtilisin/Kexin Type 9 Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. South Korea Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. India Proprotein Convertase Subtilisin/Kexin Type 9 Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. India Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Australia Proprotein Convertase Subtilisin/Kexin Type 9 Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. Australia Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Taiwan Proprotein Convertase Subtilisin/Kexin Type 9 Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Taiwan Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Indonesia Proprotein Convertase Subtilisin/Kexin Type 9 Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Indonesia Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Thailand Proprotein Convertase Subtilisin/Kexin Type 9 Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Thailand Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Malaysia Proprotein Convertase Subtilisin/Kexin Type 9 Sales Growth Rate (2015-2020) (K Pcs)
Figure 82. Malaysia Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Philippines Proprotein Convertase Subtilisin/Kexin Type 9 Sales Growth Rate (2015-2020) (K Pcs)
Figure 84. Philippines Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Vietnam Proprotein Convertase Subtilisin/Kexin Type 9 Sales Growth Rate (2015-2020) (K Pcs)
Figure 86. Vietnam Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 87. Asia Pacific Proprotein Convertase Subtilisin/Kexin Type 9 Market Share by Type in 2019
Figure 88. Asia Pacific Proprotein Convertase Subtilisin/Kexin Type 9 Market Share by Application in 2019
Figure 89. Latin America Proprotein Convertase Subtilisin/Kexin Type 9 Sales Growth Rate 2015-2020 (K Pcs)
Figure 90. Latin America Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 91. Latin America Proprotein Convertase Subtilisin/Kexin Type 9 Sales Market Share by Country in 2019
Figure 92. Latin America Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Market Share by Country in 2019
Figure 93. Mexico Proprotein Convertase Subtilisin/Kexin Type 9 Sales Growth Rate (2015-2020) (K Pcs)
Figure 94. Mexico Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Brazil Proprotein Convertase Subtilisin/Kexin Type 9 Sales Growth Rate (2015-2020) (K Pcs)
Figure 96. Brazil Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Argentina Proprotein Convertase Subtilisin/Kexin Type 9 Sales Growth Rate (2015-2020) (K Pcs)
Figure 98. Argentina Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 99. Latin America Proprotein Convertase Subtilisin/Kexin Type 9 Market Share by Type in 2019
Figure 100. Latin America Proprotein Convertase Subtilisin/Kexin Type 9 Market Share by Application in 2019
Figure 101. Middle East and Africa Proprotein Convertase Subtilisin/Kexin Type 9 Sales Growth Rate 2015-2020 (K Pcs)
Figure 102. Middle East and Africa Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 103. Middle East and Africa Proprotein Convertase Subtilisin/Kexin Type 9 Sales Market Share by Country in 2019
Figure 104. Middle East and Africa Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Market Share by Country in 2019
Figure 105. Turkey Proprotein Convertase Subtilisin/Kexin Type 9 Sales Growth Rate (2015-2020) (K Pcs)
Figure 106. Turkey Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Saudi Arabia Proprotein Convertase Subtilisin/Kexin Type 9 Sales Growth Rate (2015-2020) (K Pcs)
Figure 108. Saudi Arabia Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. U.A.E Proprotein Convertase Subtilisin/Kexin Type 9 Sales Growth Rate (2015-2020) (K Pcs)
Figure 110. U.A.E Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 111. Middle East and Africa Proprotein Convertase Subtilisin/Kexin Type 9 Market Share by Type in 2019
Figure 112. Middle East and Africa Proprotein Convertase Subtilisin/Kexin Type 9 Market Share by Application in 2019
Figure 113. North America Proprotein Convertase Subtilisin/Kexin Type 9 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 114. North America Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Europe Proprotein Convertase Subtilisin/Kexin Type 9 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 116. Europe Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Asia Pacific Proprotein Convertase Subtilisin/Kexin Type 9 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 118. Asia Pacific Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Latin America Proprotein Convertase Subtilisin/Kexin Type 9 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 120. Latin America Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Middle East and Africa Proprotein Convertase Subtilisin/Kexin Type 9 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 122. Middle East and Africa Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Porter's Five Forces Analysis
Figure 124. Channels of Distribution
Figure 125. Distributors Profiles
Figure 126. Bottom-up and Top-down Approaches for This Report
Figure 127. Data Triangulation
Figure 128. Key Executives Interviewed
ユニバーサルテストシステムの世界市場（～2026年） Universal Testing Systems include electromechanical series and industrial series to perform static testing, including tensile and compression applications. Market Analysis and Insights: Global Universal Testing Systems Market The global Universal Testing Systems market size is projected to reach US$…